2022 Year in Review Banner. 2022 Year in Review Banner.

Year in Review: 2022

A Note from Oncology Leadership

UPMC Hillman Cancer Center (Hillman) is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center and the preeminent institution in western Pennsylvania for providing cancer care; conducting basic, translational, clinical, and population science research; and educating the next generation of cancer researchers and physicians. At Hillman, we are quickly advancing the latest research discoveries into pioneering therapies that can benefit the more than 113,000 patients seen each year throughout our integrated cancer care delivery network.

In 2022, we at UPMC Hillman Cancer Center greatly expanded the capabilities for the research that is done here every day to envision life without cancer. While you learn more about our highlights from the last year, we hope you consider voting for UPMC Presbyterian Shadyside in the upcoming U.S. News & World Report "Best Hospitals" survey.

Robert Ferris HR

Robert L. Ferris, MD, PhD
Director, UPMC Hillman Cancer Center
Hillman Professor of Oncology, and Professor of Otolaryngology, of Immunology, and of Radiation Oncology

Image of Dr. Stanley.

Stanley M. Marks, MD
Chair, UPMC Hillman Cancer Center
Chief of the Division of Hematology/Oncology at UPMC Shadyside
Clinical Professor of Medicine at the University of Pittsburgh School of Medicine

One of the best national hospitals, ranked in cancer care by U.S. News and World Report.UPMC Presbyterian Shadyside Nationally Ranked for Excellence in Oncology

Affiliated with the University of Pittsburgh School of Medicine, UPMC Presbyterian Shadyside is proud to be nationally recognized by U.S. News & World Report for excellence in oncology.